REFERENCES
1. Dickinson, K. M. & Collaco, J. M. Cystic fibrosis. Pediatr Rev 42, 55-67( 2021).
2. Scotet, V., L ' Hostis, C. & Férec, C. The changing epidemiology of cystic fibrosis: Incidence, survival and impact of the CFTR gene discovery. Genes( Basel) 11( 2020).
3. Jain, R. Diagnosing cystic fibrosis in adults: Better late than never. Ann Am Thorac Soc 15, 1140-1141( 2018).
4. Xie, L., et al. Prevalence and trends in cystic fibrosis among the United States medicaid population in 2008 And 2009. Value in Health 17, A57( 2014).
5. Cystic fibrosis foundation. Vol. 2025( Cystic Fibrosis Foundation, 2022).
6. Collins, F. S. Realizing the dream of molecularly targeted therapies for cystic fibrosis. N Engl J Med 381, 1863-1865( 2019).
7. Chen, Q., Shen, Y. & Zheng, J. A review of cystic fibrosis: Basic and clinical aspects. Animal Model Exp Med 4, 220-232( 2021).
8. Grasemann, H. & Ratjen, F. Cystic fibrosis. N Engl J Med 389, 1693-1707( 2023).
9. Da Silva Sanchez, A., Paunovska, K., Cristian, A. & Dahlman, J. E. Treating cystic fibrosis with mRNA and CRISPR. Hum Gene Ther 31, 940-955( 2020).
10. Diab Cáceres, L. & Zamarrón de Lucas, E. Cystic fibrosis: Epidemiology, clinical manifestations, diagnosis and treatment. Med Clin( Barc) 161, 389-396( 2023).
11. Rosenfeld, M., et al. Real-world associations of US cystic fibrosis newborn screening programs with nutritional and pulmonary outcomes. JAMA Pediatrics 176, 990-999( 2022).
12. Coverstone, A. M. & Ferkol, T. W. Early diagnosis and intervention in cystic fibrosis: Imagining the unimaginable. Front Pediatr 8, 608821( 2020).
13. McBennett, K. A., Davis, P. B. & Konstan, M. W. Increasing life expectancy in cystic fibrosis: Advances and challenges. Pediatr Pulmonol 57 Suppl 1, S5-s12( 2022).
14. National Guideline, A. National institute for health and care excellence: Guidelines in Cystic Fibrosis: Diagnosis and management( National Institute for Health and Care Excellence( NICE) Copyright © NICE 2017., London, 2017).
15. Mountain state cystic fibrosis center. Vol. 2024( 2024).
16. 16. Blankenship, S., et al. What the future holds: cystic fibrosis and aging. Front Med( Lausanne) 10, 1340388( 2023).
17. Cystic fibrosis. Vol. 2021( 2024).
18. 18. 2023 CF patient registry program specific report. Vol. 2025( Cystic Fibrosis Foundation, 2023).
19. Kerem, E., Conway, S., Elborn, S. & Heijerman, H. Standards of care for patients with cystic fibrosis: A european consensus. J Cyst Fibros 4, 7-26( 2005).
20. Office, D. & Heeres, I. Transition from paediatric to adult care in cystic fibrosis. Breathe( Sheff) 18, 210157( 2022).
21. Baker, A. M., Riekert, K. A., Sawicki, G. S. & Eakin, M. N. CF RISE: Implementing a clinic-based transition program. Pediatr Allergy Immunol Pulmonol 28, 250-254( 2015).
22. Burgel, P. R., Burnet, E., Regard, L. & Martin, C. The changing epidemiology of cystic fibrosis: The implications for adult care. Chest 163, 89-99( 2023).
23. Hong, I., Wilson, B., Gross, T., Conley, J. & Powers, T. Challenging terrains: sociospatial analysis of primary health care access disparities in West Virginia. Appl Spat Anal Policy 16, 141-161( 2023).
24. Statistics about the population of West Virginia Vol. 2024( West Virginia Department of Health).
25. Singh, H., et al. Cystic fibrosis-related mortality in the United States from 1999 to 2020: an observational analysis of time trends and disparities. Sci Rep 13, 15030( 2023).
26. Jessup, M. M., et al. 269 Living with cystic fibrosis in a remote or rural area. Journal of Cystic Fibrosis 14, S127( 2015).
27. Hempstead, S. E., Fredkin, K., Hovater, C. & Naureckas, E. T. Patient and family participation in clinical guidelines development: The cystic fibrosis foundation experience. J Particip Med 12, e17875( 2020).
28. Kolluri, S., et al. Telehealth in response to the rural health disparity. Health Psychol Res 10, 37445( 2022).
29. Chapman, K. D. & Moffett, K. S. Cystic fibrosis and COVID-19. South Med J 113, 422( 2020).
30. Haggerty, T., et al. Telemedicine versus in-person primary care: Impact on visit completion rate in a rural appalachian population. J Am Board Fam Med 35, 475-484( 2022).
31. Desimone, M. E., Sherwood, J., Soltman, S. C. & Moran, A. Telemedicine in cystic fibrosis. J Clin Transl Endocrinol 26, 100270( 2021).
32. Raza, T., Joshi, M., Schapira, R. M. & Agha, Z. Pulmonary telemedicine— A model to access the subspecialist services in underserved rural areas. International Journal of Medical Informatics 78, 53-59( 2009).
33. Tagliente, I., Trieste, L., Solvoll, T., Murgia, F. & Bella, S. Telemonitoring in cystic fibrosis: A 4-year assessment and simulation for the next 6 years. Interact J Med Res 5, e11( 2016).
34. Jessup, M., Smyth, W., Abernethy, G., Shields, L. & Douglas, T. Family-centred care for families living with cystic fibrosis in a rural setting: A qualitative study. J Clin Nurs 27, e590-e599( 2018).
35. Middleton, P. G., et al. Elexacaftor- Tezacaftor-Ivacaftor for cystic fibrosis
West Virginia Medical Journal • December 2025 • 17